Evidence map›Paper›PMID 34394833›Full record

ReviewOxidative medicine and cellular longevity2021

Endoplasmic Reticulum Stress in Diabetic Nephrology: Regulation, Pathological Role, and Therapeutic Potential.

Lihua Ni, Cheng Yuan, Xiaoyan Wu

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Gelatin Hydrolysate from Bigeye Snapper (International journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Endoplasmic Reticulum Stress in Renal Cell Carcinoma.International journal of molecular sciences · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lihua NiDepartment of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.ORCID https://orcid.org/0000-0002-0456-3279
Cheng YuanDepartment of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.ORCID https://orcid.org/0000-0002-0226-614X
Xiaoyan WuDepartment of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.ORCID https://orcid.org/0000-0002-3231-9775
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent progress has been made in understanding the roles and mechanisms of endoplasmic reticulum (ER) stress in the development and pathogenesis of diabetic nephropathy (DN). Hyperglycemia induces ER stress and apoptosis in renal cells. The induction of ER stress can be cytoprotective or cytotoxic. Experimental treatment of animals with ER stress inhibitors alleviated renal damage. Considering these findings, the normalization of ER stress by pharmacological agents is a promising approach to prevent or arrest DN progression. The current article reviews the mechanisms, roles, and therapeutic aspects of these findings.

Indexed as

Endoplasmic Reticulum StressAnimalsDiabetes Mellitus, ExperimentalDiabetic NephropathieseIF-2 KinaseErbB ReceptorsKidneyProtective AgentsReactive Oxygen SpecieseIF-2 KinaseErbB ReceptorsProtective AgentsReactive Oxygen Species

Identifiers

PMID34394833
PMCPMC8355967
OpenAlexW3192545472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.